FDAnews and VOI Consulting Announce the Launch of the New PDMSN Advisor Newsletter

    FALLS CHURCH, Va., June 27 /PRNewswire/ -- FDAnews and Value of Insight
 (VOI) Consulting, publishers of PharmaHandbook and GenericHandbook,
 announce the launch of PDMSN Advisor, a new online newsletter for
 pharmaceutical sales and marketing professionals.
     With content and commentary from Todd Clark, president of VOI
 Consulting and a well-known author, each biweekly issue of PDMSN Advisor
 provides:
     -- Two in-depth articles focused on challenges and opportunities in:
        -- Pharmaceutical Marketing and Sales -- web advertising, specialty
           pharma, approval odds for key categories and more
        -- Device Marketing and Sales -- off-label implications, Chinese device
           market, legal actions against device manufacturers and more
     -- Timely tips applicable to both the pharmaceutical and device industries
     -- Briefs that describe what to watch for in months ahead -- focused on
        U.S. developments, but also includes international coverage when you'll
        be affected by changes abroad
     -- Quick and easy resource links for additional information
 
     PDMSN Advisor will help readers:
 
     -- Sidestep unwanted attention from the state attorneys general
     -- Be first with market statistics and studies for faster, informed
        decisions
     -- Keep current on emerging compliance demands and skirt high-dollar
        regulatory battles
     -- Effectively judge the latest techniques -- find out what's working and
        what's not
     -- Deploy shrewd strategies to keep your sales and marketing department
        running "lean and mean"
 
     Visit http://www.PDMSN.com to subscribe.
     FDAnews provides domestic and international regulatory, legislative,
 and business news and information for executives in industries regulated by
 the U.S. FDA and the European Medicines Agency. Pharmaceutical and medical
 device professionals rely on FDAnews' print and electronic newsletters,
 books and conferences to stay in compliance with international standards
 and the FDA's complex and ever-changing regulations.
     With a focus on the pre and post-approval marketing of pharmaceuticals,
 Value of Insight (VOI) Consulting, Inc. offers a wide array of strategic
 consulting services to the healthcare industry. In addition to 9 of the top
 15 drug companies, VOI clients have included biotech firms, investment
 banks, and cutting-edge healthcare technology services. VOI is also the
 publisher of several industry-leading reference publications including
 PharmaHandbook and GenericHandbook.
 
 

SOURCE FDAnews